According to a survey conducted by Florence Healthcare, 47% of research sites had adopted e-Consent by December 2020, just 8 months after the WHO declared an official pandemic. By July 2021, 75% of research sites had either used it or were looking into it. In conclusion – the decentralized consent process is here to stay.
While paper informed consent forms (ICFs) remain the most widely utilized method of consent, they have long been deemed inadequate, implemented primarily for cost and familiarity. A recent survey of 179 different clinicians conducted by Chrysalis Advisory and CT:IQ showcases the negative clinical perception that prevails around paper consent forms. According to the survey:
• 72% considered paper consent forms to be too long
• 62% found paper consent forms to be too complex
• 38% thought that paper consent forms impaired participant comprehension In stark contrast, the same survey showcased positive clinical perceptions around e-Consent’s ability to improve clinical research. Specifically:
• 67% expected e-Consent to enhance patient comprehension
• 59% reported seeing e-Consent as the solution to providing adequate information to culturally and linguistically diverse populations
Click here to read the full text.
References
- Why eConsent Primes Patients And Studies For Success. (n.d.). https://www.cellandgene.com/doc/why-econsent-primes-patients-and-studies-for-success-0001
Disclaimers
- The material in these reviews is from various public open-access sources, meant for educational and informational purposes only
- Any personal opinions expressed are those of only the author(s) and are not intended to represent the position of any organization(s)
- No official support by any organization(s) has been provided or should be inferred
